company background image
688091

Shanghai Yizhong Pharmaceutical SHSE:688091 Stock Report

Last Price

CN¥78.09

Market Cap

CN¥11.2b

7D

2.8%

1Y

128.9%

Updated

26 Jan, 2023

Data

Company Financials

Shanghai Yizhong Pharmaceutical Co., Ltd.

SHSE:688091 Stock Report

Mkt Cap: CN¥11.2b

688091 Stock Overview

Shanghai Yizhong Pharmaceutical Co., Ltd.

688091 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Became profitable this year

Risk Analysis

High level of non-cash earnings


My Notes

New

Notes are coming soon

Shanghai Yizhong Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai Yizhong Pharmaceutical
Historical stock prices
Current Share PriceCN¥78.09
52 Week HighCN¥146.24
52 Week LowCN¥33.46
Beta0
1 Month Change21.13%
3 Month Change-2.99%
1 Year Change128.88%
3 Year Changen/a
5 Year Changen/a
Change since IPO116.78%

Recent News & Updates

Recent updates

Shareholder Returns

688091CN PharmaceuticalsCN Market
7D2.8%2.0%1.3%
1Y128.9%-1.2%-8.4%

Return vs Industry: 688091 exceeded the CN Pharmaceuticals industry which returned -1.2% over the past year.

Return vs Market: 688091 exceeded the CN Market which returned -8.4% over the past year.

Price Volatility

Is 688091's price volatile compared to industry and market?
688091 volatility
688091 Average Weekly Movement6.5%
Pharmaceuticals Industry Average Movement6.6%
Market Average Movement5.2%
10% most volatile stocks in CN Market8.4%
10% least volatile stocks in CN Market3.2%

Stable Share Price: 688091 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 688091's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2009122Jingsong Zhouhttps://www.yizhongpharma.com

Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It develops a dosage form of paclitaxel, an anti-tumor chemotherapeutic. Shanghai Yizhong Pharmaceutical Co., Ltd.

Shanghai Yizhong Pharmaceutical Co., Ltd. Fundamentals Summary

How do Shanghai Yizhong Pharmaceutical's earnings and revenue compare to its market cap?
688091 fundamental statistics
Market CapCN¥11.24b
Earnings (TTM)CN¥120.29m
Revenue (TTM)CN¥170.40m

93.4x

P/E Ratio

65.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
688091 income statement (TTM)
RevenueCN¥170.40m
Cost of RevenueCN¥12.09m
Gross ProfitCN¥158.31m
Other ExpensesCN¥38.02m
EarningsCN¥120.29m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.84
Gross Margin92.91%
Net Profit Margin70.59%
Debt/Equity Ratio0%

How did 688091 perform over the long term?

See historical performance and comparison